Role of DJ-1 SiRNA in Reverse Sensitivity of Breast Cancer Cells to Chemotherapy and Its Possible Mechanism

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2015 Aug 12

PMID 26261582

Citations 9

Authors

Guo-Qiang Zhang

Chuan He

Li Tao

Feng Liu

Affiliations

Soon will be listed here.

Abstract

Breast cancer which has a high incidence rate is the 2(nd) lethal diseases only followed by lung cancer in women. How to improve the recovery rate is the principal problem should be solved in clinical. Previous studies demonstrated the importance of DJ-1 in the existence of breast cancer for the secreted of protein into serum by breast cancer cells both in vitro and in vivo. So the DJ-1 probably could be selected as the target in breast cancer treatment. Adriamycin resistance breast cancer cells MCF-7 and DJ-1 siRNA plasmid were employed to explore the potential clinical application of DJ-1 in this study. Our results showed that the sensitivity of cancer cells to chemotherapeutics was significantly improved with the transfection of DJ-1 siRNA. Further mechanism studies indicated the role of PI3K/AKT/MTOR pathway in the improvement of apoptosis after treatment with adriamycin in DJ-1 silence group.

Citing Articles

Ethanolic extract from Sophora moorcroftiana inhibit cell proliferation and alter the mechanical properties of human cervical cancer.

Guo M, Guo D, Liao L, Zhang X, Wang Z, Zhou Q BMC Complement Med Ther. 2024; 24(1):212.

PMID: 38831394 PMC: 11149180. DOI: 10.1186/s12906-024-04502-5.

Elucidating the susceptibility to breast cancer: an in-depth proteomic and transcriptomic investigation into novel potential plasma protein biomarkers.

Wang Y, Yi K, Chen B, Zhang B, Jidong G Front Mol Biosci. 2024; 10:1340917.

PMID: 38304232 PMC: 10833003. DOI: 10.3389/fmolb.2023.1340917.

Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.

Jin W J Clin Med. 2020; 9(5).

PMID: 32357493 PMC: 7288009. DOI: 10.3390/jcm9051256.

Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies.

Xu L, Lee J, Hao S, Ling X, Brooks J, Wang S PLoS One. 2019; 14(8):e0221051.

PMID: 31404106 PMC: 6690541. DOI: 10.1371/journal.pone.0221051.

Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.

Xiang S, Dauchy R, Hoffman A, Pointer D, Frasch T, Blask D J Pineal Res. 2019; 67(2):e12586.

PMID: 31077613 PMC: 6750268. DOI: 10.1111/jpi.12586.

References

Le Naour F, Misek D, Krause M, Deneux L, Giordano T, Scholl S . Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res. 2001; 7(11):3328-35. View

Kim R, Peters M, Jang Y, Shi W, Pintilie M, Fletcher G . DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell. 2005; 7(3):263-73. DOI: 10.1016/j.ccr.2005.02.010. View

Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Ariga H . DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun. 1997; 231(2):509-13. DOI: 10.1006/bbrc.1997.6132. View

Davidson B, Hadar R, Schlossberg A, Sternlicht T, Slipicevic A, Skrede M . Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum Pathol. 2007; 39(1):87-95. DOI: 10.1016/j.humpath.2007.05.014. View

Takahashi K, Taira T, Niki T, Seino C, Ariga H . DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J Biol Chem. 2001; 276(40):37556-63. DOI: 10.1074/jbc.M101730200. View

Sarbassov D, Guertin D, Ali S, Sabatini D . Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005; 307(5712):1098-101. DOI: 10.1126/science.1106148. View

Okada M, Matsumoto K, Niki T, Taira T, Iguchi-Ariga S, Ariga H . DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice. Biol Pharm Bull. 2002; 25(7):853-6. DOI: 10.1248/bpb.25.853. View

Junn E, Taniguchi H, Jeong B, Zhao X, Ichijo H, Mouradian M . Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci U S A. 2005; 102(27):9691-6. PMC: 1172235. DOI: 10.1073/pnas.0409635102. View

Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung S . SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 2006; 127(1):125-37. DOI: 10.1016/j.cell.2006.08.033. View

10.

van Engeland M, Ramaekers F, Schutte B, Reutelingsperger C . A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 1996; 24(2):131-9. DOI: 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M. View

11.

Yuen H, Chan Y, Law S, Srivastava G, El-Tanani M, Mak T . DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008; 17(12):3593-602. DOI: 10.1158/1055-9965.EPI-08-0214. View

12.

Chung C, Lee S, Hwang S, Park E . Systematic review of exercise effects on health outcomes in women with breast cancer. Asian Nurs Res (Korean Soc Nurs Sci). 2014; 7(3):149-59. DOI: 10.1016/j.anr.2013.07.005. View

13.

Ottolini D, Cali T, Negro A, Brini M . The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering. Hum Mol Genet. 2013; 22(11):2152-68. DOI: 10.1093/hmg/ddt068. View

14.

Grzmil M, Voigt S, Thelen P, Hemmerlein B, Helmke K, Burfeind P . Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Int J Oncol. 2003; 24(1):97-105. View

15.

Clements C, McNally R, Conti B, Mak T, Ting J . DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A. 2006; 103(41):15091-6. PMC: 1586179. DOI: 10.1073/pnas.0607260103. View

16.

Mitsumoto A, Nakagawa Y . DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic Res. 2002; 35(6):885-93. DOI: 10.1080/10715760100301381. View

17.

MacKeigan J, Clements C, Lich J, Pope R, Hod Y, Ting J . Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res. 2003; 63(20):6928-34. View

18.

Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga S, Ariga H . DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol Cancer Res. 2003; 1(4):247-61. View

19.

Hod Y, Pentyala S, Whyard T, El-Maghrabi M . Identification and characterization of a novel protein that regulates RNA-protein interaction. J Cell Biochem. 1999; 72(3):435-44. View

20.

Zhang Y, Duan Y, Zheng X . Targeting the mTOR kinase domain: the second generation of mTOR inhibitors. Drug Discov Today. 2011; 16(7-8):325-31. PMC: 3073023. DOI: 10.1016/j.drudis.2011.02.008. View